Two therapies with their roots in antibody technology developed in the LMB and the Scripps Research Institute* have recently emerged as promising new drug candidates to treat lupus, a potentially fatal autoimmune disease, and anthrax, a pressing concern due to bioterrorism. The drug candidates—belimumab (BENLYSTATM, formerly LumphoStat-B®), developed by Human Genome Sciences with GlaxoSmithKine as […]
Human Antibodies developed for Treatment of Lupus and Anthrax
DNA pioneers to get new £197m lab
“A £67m investment by the government has cleared the way for the rebuilding of the internationally-renowned Laboratory of Molecular Biology (LMB). The Cambridge-based laboratory has produced 14 Nobel Prize winners and is where DNA coding was first unravelled. The funds enable the Medical Research Council, which runs LMB, to meet the £197m cost of a […]